Literature DB >> 11594944

Risk factors for age-related maculopathy: the Visual Impairment Project.

C A McCarty1, B N Mukesh, C L Fu, P Mitchell, J J Wang, H R Taylor.   

Abstract

OBJECTIVE: To describe the risk factors and associated population attributable risk for age-related maculopathy (ARM) and age-related macular degeneration (AMD) in Australians aged 40 years and older.
METHODS: Residents were recruited from 9 randomly selected urban clusters and 4 randomly selected rural clusters in Victoria, Australia. At locally established test sites, the following information was collected: visual acuity, medical and health history, lifetime sunlight exposure, dietary intake, and fundus photographs. Age-related maculopathy and AMD were graded from the fundus photographs using an international classification and grading system. Backwards logistic regression was used to identify the independent risk factors for ARM and AMD.
RESULTS: The participation rate was 83% (n = 3271) among the urban residents and 92% (n = 1473) among the rural residents. Gradable fundus photographs of either eye were available for 4345 (92%) of the 4744 participants. There were 656 cases of ARM, giving a weighted prevalence of 15.1% (95% confidence limit [CL], 13.8, 16.4); and there were 30 cases of AMD, giving a weighted prevalence of 0.69% (95% CL, 0.33, 1.03). In multiple logistic regression, the risk factors for AMD were as follows: age (odds ratio [OR], 1.23; 95% CL, 1.17, 1.29), smoked cigarettes for longer than 40 years (OR, 2.39; 95% CL, 1.02, 5.57), and ever taken angiotensin-converting enzyme inhibitors (OR, 3.26; 95% CL, 1.33, 8.01). The magnitude of all of these risk factors was slightly less for ARM, and having ever taken blood cholesterol-lowering medications was also significant (OR, 1.67; 95% CL, 1.12, 2.47; P =.001).
CONCLUSION: Smoking is the only modifiable risk factor for ARM and AMD, among the many environmental and systemic factors that were assessed.

Entities:  

Mesh:

Year:  2001        PMID: 11594944     DOI: 10.1001/archopht.119.10.1455

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  73 in total

Review 1.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  How much blue light should an IOL transmit?

Authors:  M A Mainster; J R Sparrow
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

3.  Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope.

Authors:  Henrike Wüstemeyer; Andreas Moessner; Cornelia Jahn; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-07-17       Impact factor: 3.117

4.  The association between statin use and age related maculopathy.

Authors:  G McGwin; C Owsley; C A Curcio; R J Crain
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

5.  The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study.

Authors:  G McGwin; T A Hall; A Xie; C Owsley
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

6.  Macular pigment density in age-related maculopathy.

Authors:  Cornelia Jahn; Henrike Wüstemeyer; Christian Brinkmann; Sandra Trautmann; Andreas Mössner; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-02       Impact factor: 3.117

7.  Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non-tinted intraocular lenses.

Authors:  K Hayashi; H Hayashi
Journal:  Br J Ophthalmol       Date:  2006-04-05       Impact factor: 4.638

Review 8.  Role of Lipids in Retinal Vascular and Macular Disorders.

Authors:  Gunjan Prakash; Rachit Agrawal; Tanie Natung
Journal:  Indian J Clin Biochem       Date:  2016-03-08

9.  Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project.

Authors:  H T V Vu; L Robman; C A McCarty; H R Taylor; A Hodge
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

10.  Statin use and the five-year incidence and progression of age-related macular degeneration.

Authors:  Ronald Klein; Michael D Knudtson; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2007-05-02       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.